Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Illumina, Inc.(ILMN) | 119,196 | 119,196 | 0 | $16.37M | $12.44M | 13.27% | -$3.93M |
| Harmony Biosciences Holdings, Inc.(HRMY) | 368,665 | 368,665 | 0 | $12.38M | $11.12M | 11.87% | -$1.26M |
| Merus N V | 89,516 | 120,038 | +30,522 | $4.03M | $7.10M | 7.58% | +$3.07M |
| Geron Corporation(GERN) | 1,324,550 | 1,373,550 | +49,000 | $4.37M | $5.82M | 6.21% | +$1.45M |
| Oculis Holding AG(OCS) | 436,378 | 436,378 | 0 | $5.26M | $5.21M | 5.56% | -$43.6K |
| Incyte Corporation(INCY) | 74,022 | 74,022 | 0 | $4.22M | $4.49M | 4.79% | +$270.2K |
| Exscientia PlcADS | 859,892 | 859,892 | 0 | $4.92M | $4.39M | 4.68% | -$533.1K |
| Xenon Pharmaceuticals Inc.(XENE) | 106,680 | 106,680 | 0 | $4.59M | $4.16M | 4.44% | -$433.1K |
| Longboard Pharmaceuticals In | 118,255 | 144,570 | +26,315 | $2.55M | $3.91M | 4.17% | +$1.35M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 96,100 | 106,100 | +10,000 | $2.41M | $3.63M | 3.87% | +$1.21M |
| Standard BioTools Inc.(LAB) | 1,883,179 | 1,883,179 | 0 | $5.10M | $3.33M | 3.56% | -$1.77M |
| BeOne Medicines AGADR(ONC) | 23,022 | 23,022 | 0 | $3.60M | $3.28M | 3.50% | -$315.9K |
| Kalvista Pharmaceuticals Inc | 219,277 | 219,277 | 0 | $2.60M | $2.58M | 2.76% | -$17.5K |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 49,120 | 49,120 | 0 | $2.13M | $2.02M | 2.15% | -$111.5K |
| Tourmaline Bio Inc | 20,987 | 146,800 | +125,813 | $480.6K | $1.89M | 2.01% | +$1.41M |
| Rani Therapeutics Holdings, Inc.CL A(RANI) | 493,584 | 493,584 | 0 | $1.54M | $1.88M | 2.00% | +$340.6K |
| Ascendis Pharma A/SADR(ASND) | 13,600 | 13,600 | 0 | $2.06M | $1.85M | 1.98% | -$201.1K |
| Replimune Group, Inc.(REPL) | 204,939 | 204,939 | 0 | $1.67M | $1.84M | 1.97% | +$170.1K |
| Acadia Pharmaceuticals Inc | 102,984 | 102,984 | 0 | $1.90M | $1.67M | 1.79% | -$230.7K |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 5,682 | 5,682 | 0 | $1.52M | $1.59M | 1.70% | +$74.5K |
| Exelixis, Inc.(EXEL) | 64,200 | 64,200 | 0 | $1.52M | $1.44M | 1.54% | -$80.9K |
| Zai Lab LimitedADR(ZLAB) | 0 | 55,000 | +55,000 | $0 | $953.1K | 1.02% | +$953.1K |
| BioMarin Pharmaceutical Inc.(BMRN) | 10,815 | 10,815 | 0 | $944.6K | $890.4K | 0.95% | -$54.2K |
| Bolt Biotherapeutics Inc | 1,166,952 | 1,166,952 | 0 | $1.63M | $875.2K | 0.93% | -$758.5K |
| Entrada Therapeutics, Inc.(TRDA) | 49,082 | 49,082 | 0 | $695.5K | $699.4K | 0.75% | +$3.9K |
| Athira Pharma Inc | 180,000 | 180,000 | 0 | $493.2K | $477.0K | 0.51% | -$16.2K |
| Pacific Biosciences of California, Inc.(PACB) | 274,488 | 274,488 | 0 | $1.03M | $376.0K | 0.40% | -$653.3K |
| Cabaletta Bio, Inc.(CABA) | 47,150 | 47,150 | 0 | $804.4K | $352.7K | 0.38% | -$451.7K |
| Bicycle Therapeutics PlcADS | 0 | 17,300 | +17,300 | $0 | $350.2K | 0.37% | +$350.2K |
| Roivant Sciences Ltd.SHS(ROIV) | 32,470 | 32,470 | 0 | $342.2K | $343.2K | 0.37% | +$974 |
| Kymera Therapeutics, Inc.(KYMR) | 10,875 | 10,875 | 0 | $437.2K | $324.6K | 0.35% | -$112.6K |
| GRAIL, Inc.(GRAL) | 0 | 19,866 | +19,866 | $0 | $305.3K | 0.33% | +$305.3K |
| Revolution Medicines, Inc.(RVMD) | 7,300 | 7,300 | 0 | $235.3K | $283.3K | 0.30% | +$48.0K |
| Springworks Therapeutics Inc | 7,450 | 7,450 | 0 | $366.7K | $280.6K | 0.30% | -$86.0K |
| ALX Oncology Holdings Inc.(ALXO) | 41,950 | 41,950 | 0 | $467.7K | $253.0K | 0.27% | -$214.8K |
| Immunocore Holdings plcADS(IMCR) | 6,750 | 6,750 | 0 | $438.8K | $228.8K | 0.24% | -$210.0K |
| Affimed N V | 37,247 | 37,247 | 0 | $197.4K | $203.0K | 0.22% | +$5.6K |
| Immatics N.V.SHS(IMTX) | 15,700 | 15,700 | 0 | $165.0K | $182.4K | 0.19% | +$17.4K |
| Biomea Fusion, Inc.(BMEA) | 40,000 | 40,000 | 0 | $598.0K | $180.0K | 0.19% | -$418.0K |
| AbCellera Biologics Inc.(ABCL) | 50,971 | 50,971 | 0 | $230.9K | $150.9K | 0.16% | -$80.0K |
| Dbv Technologies S AADR | 0 | 185,475 | +185,475 | $0 | $148.6K | 0.16% | +$148.6K |
| Aerovate Therapeutics Inc | 47,936 | 47,936 | 0 | $1.42M | $79.6K | 0.08% | -$1.34M |
| Kodiak Sciences Inc.(KOD) | 31,922 | 31,922 | 0 | $167.9K | $75.0K | 0.08% | -$92.9K |
| Fibrogen Inc | 62,106 | 62,106 | 0 | $145.9K | $55.4K | 0.06% | -$90.5K |
| Alpine Immune Sciences Inc | 263,940 | 0 | -263,940 | $10.46M | $0 | — | -$10.46M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 36,847 | 0 | -36,847 | $187.2K | $0 | — | -$187.2K |
| Dbv Technologies S AADR | 370,950 | 0 | -370,950 | $277.9K | $0 | — | -$277.9K |
| Galera Therapeutics Inc | 613,223 | 0 | -613,223 | $85.9K | $0 | — | -$85.9K |
| Neumora Therapeutics, Inc.(NMRA) | 63,315 | 0 | -63,315 | $870.6K | $0 | — | -$870.6K |